Biological Age: A New Health Risk Revealed

A significant study involving over 3,000 participants has identified accelerated biological aging as a long-term health risk. This research, published in Scientific Reports, examined the link between the age of one's cells and various health outcomes.

Accelerated biological age was associated with a higher risk of death and cardiovascular disease across the board. Notably, women with accelerated biological aging also exhibited a greater risk of developing dementia.

Researchers utilized data from the Framingham Offspring Study, analyzing biomarkers like cholesterol and blood sugar. Participants were categorized into accelerated, decelerated, or concordant biological age groups. On average, men with accelerated biological age were four years older than their chronological age, while women were 2.5 years older.

The study followed participants for over two decades, observing significant correlations. Men with accelerated biological age had a 1.6-fold higher risk of cardiovascular disease, and women had an 1.8-fold higher risk compared to those with decelerated biological age. Mortality risk doubled for both sexes with accelerated biological age.

While the study indicates increased dementia risk for women with accelerated biological age, this link was not statistically significant for men. Sensitivity analyses confirmed a higher dementia risk for women with both accelerated and concordant biological ages compared to decelerated biological ages.

Experts emphasize that this observational study cannot prove causation but suggests biological age can be a useful proxy for aging processes. The lack of a standardized method for calculating biological age is a noted limitation, as is the predominantly white, European demographic of the study participants, which affects generalizability.

While not requiring immediate clinical practice changes, the findings may prompt important conversations between patients and healthcare providers about modifiable risk factors. Experts suggest that biological age could help identify individuals at higher risk for adverse outcomes not evident through single biomarker tests. Future research aims to explore factors contributing to accelerated biological aging and develop standardized definitions.